Clinic
Abbeville General Hospital
Abbeville General Hospital was paid $1.78M by Medicaid between May 2019 and Dec 2024, across 18 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoABBEVILLE GENERAL HOSPITAL
ABBEVILLE, LA 70510
ABBEVILLE, LA 70510
33aNPI1619458247assigned 08/22/2018
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.78M
24GClaims66,540
24DCodes billed18
24AFirst – last monthMay 2019 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Louisiana
Rank by total paid#31 of 98
Median peer was paid$694K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 3,716 | $43K | |
| 2020 | 8,305 | $108K | |
| 2021 | 11,451 | $334K | |
| 2022 | 13,811 | $427K | |
| 2023 | 16,779 | $496K | |
| 2024incomplete | 12,478 | $368K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 26,842 | 22,700 | $810K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 19% | 6,172 | 5,177 | $344K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17% | 10,218 | 8,543 | $307K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 11% | 8,606 | 7,008 | $192K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.2% | 2,822 | 2,484 | $56K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 678 | 592 | $32K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 299 | 278 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,586 | 931 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,886 | 3,055 | $6K |
| 87400 | <1% | 1,634 | 962 | $3K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 29 | 27 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 253 | 67 | $1K |
6 more codes
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 544 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 92 | $993.48 |
| 81002 | <1% | 437 | $727.39 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 524 | $331.08 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 443 | $52.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 475 | $13.26 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, DEMETRIA (DIRECTOR OF BUS OFF AND PT ACCESS)
Parent organizationABBEVILLE GENERAL HOSPITAL